ArticleNeuro-oncology advances

Longitudinal assessment of quality of life, neurocognition, and psychopathology in patients with low-grade glioma on first-line temozolomide: A feasibility study.

Amélie Darlix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.